Journal of Clinical Endocrinology & Metabolism, Vol 74, 667-672, Copyright © 1992 by Endocrine Society

ARTICLES

Compound heterozygous mutations (Arg 239----stop, Pro 342----Thr) in the CYP17 (P45017 alpha) gene lead to ambiguous external genitalia in a male patient with partial combined 17 alpha-hydroxylase/17,20-lyase deficiency

R Ahlgren, T Yanase, ER Simpson, JS Winter and MR Waterman
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235.

17 alpha-Hydroxylase deficiency is characterized by defects in either or both the 17 alpha-hydroxylase/17,20-lyase activities. We have, for the first time, elucidated the molecular basis of the deficiency in a male pseudohermaphrodite with ambiguous external genitalia resulting from partial combined deficiency of both activities. The patient is found to be a compound heterozygote, carrying two different inherited mutant alleles in the cytochrome P45017 alpha (CYP17) gene. One allele, from his mother, contains a stop codon (TGA) in place of arginine (CGA) at amino acid position 239 in exon 4. Because this occurs at the N- terminal side of the heme binding sequence, the putative resultant truncated protein is nonfunctional. The second allele, from his father, contains a missense mutation encoding the substitution of proline (CCA) by threonine (ACA) at position 342 in exon 6. Reconstruction of this mutation by site-directed mutagenesis into human P45017 alpha cDNA followed by expression in COS 1 cells leads to the same amount of immunodetectable P45017 alpha protein as found with expression of the normal P45017 alpha cDNA, although both the 17 alpha-hydroxylase and 17,20-lyase activities are found to be reduced to 40-45% of those of the normal enzyme. The presence of ambiguous external genitalia in this 46 XY individual indicates that greater than 20% of the total normal 17,20-lyase activity is required for complete virilization in the male.

This article has been cited by other articles:

				M. Taniyama, M. Tanabe, H. Saito, Y. Ban, H. Nawata, and T. Yanase Subtle 17{alpha}-Hydroxylase/17,20-Lyase Deficiency with Homozygous Y201N Mutation in an Infertile Woman J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2508 - 2511. [Abstract] [Full Text] [PDF]

				E. L. T. van den Akker, J. W. Koper, A. L. M. Boehmer, A. P. N. Themmen, M. Verhoef-Post, M. A. Timmerman, B. J. Otten, S. L. S. Drop, and F. H. De Jong Differential Inhibition of 17{alpha}-Hydroxylase and 17,20-Lyase Activities by Three Novel Missense CYP17 Mutations Identified in Patients with P450c17 Deficiency J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5714 - 5721. [Abstract] [Full Text] [PDF]

				A. Biason-Lauber, B. Kempken, E. Werder, M. G. Forest, S. Einaudi, M. B. Ranke, N. Matsuo, V. Brunelli, E. J. Schönle, and M. Zachmann 17{alpha}-Hydroxylase/17,20-Lyase Deficiency as a Model to Study Enzymatic Activity Regulation: Role of Phosphorylation J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1226 - 1231. [Abstract] [Full Text]

				R. J. Auchus and W. L. Miller Molecular Modeling of Human P450c17 (17{alpha}-Hydroxylase/ 17,20-Lyase): Insights into Reaction Mechanisms and Effects of Mutations Mol. Endocrinol., July 1, 1999; 13(7): 1169 - 1182. [Abstract] [Full Text]

				Y. Suzuki, T. Nagashima, Y. Nomura, K. Onigata, K. Nagashima, and A. Morikawa A New Compound Heterozygous Mutation (W17X, 436+5G->T) in the Cytochrome P450c17 Gene Causes 17{alpha}-Hydroxylase/17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 199 - 202. [Abstract] [Full Text]